Literature DB >> 26216635

The Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor Beds.

Melanie R Rutkowski1, Nikolaos Svoronos1, Alfredo Perales-Puchalt1, Jose R Conejo-Garcia2.   

Abstract

During tumor progression, alterations within the systemic tumor environment, or macroenvironment, result in the promotion of tumor growth, tumor invasion to distal organs, and eventual metastatic disease. Distally produced hormones, commensal microbiota residing within mucosal surfaces, myeloid cells and even the bone marrow impact the systemic immune system, tumor growth, and metastatic spread. Understanding the reciprocal interactions between the cells and soluble factors within the macroenvironment and the primary tumor will enable the design of specific therapies that have the potential to prevent dissemination and metastatic spread. This chapter will summarize recent findings detailing how the primary tumor and systemic tumor macroenvironment coordinate malignant progression.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Commensal microbiota; Emergency myelopoiesis; Hormones; MDSC; Microbiota; Premetastatic niche; Tumor microenvironment; Tumor-promoting inflammation

Mesh:

Year:  2015        PMID: 26216635      PMCID: PMC4668932          DOI: 10.1016/bs.acr.2015.04.011

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  131 in total

1.  The terminology issue for myeloid-derived suppressor cells.

Authors:  Dmitry I Gabrilovich; Vincenzo Bronte; Shu-Hsia Chen; Mario P Colombo; Augusto Ochoa; Suzanne Ostrand-Rosenberg; Hans Schreiber
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

2.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

3.  Specific gut commensal flora locally alters T cell tuning to endogenous ligands.

Authors:  Pascal Chappert; Nicolas Bouladoux; Shruti Naik; Ronald H Schwartz
Journal:  Immunity       Date:  2013-06-27       Impact factor: 31.745

4.  VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors.

Authors:  Xin Lu; Euphemia Mu; Yong Wei; Sabine Riethdorf; Qifeng Yang; Min Yuan; Jun Yan; Yuling Hua; Benjamin J Tiede; Xuemin Lu; Bruce G Haffty; Klaus Pantel; Joan Massagué; Yibin Kang
Journal:  Cancer Cell       Date:  2011-12-01       Impact factor: 31.743

5.  Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.

Authors:  Garnet L Anderson; Howard L Judd; Andrew M Kaunitz; David H Barad; Shirley A A Beresford; Mary Pettinger; James Liu; S Gene McNeeley; Ana Maria Lopez
Journal:  JAMA       Date:  2003-10-01       Impact factor: 56.272

6.  Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation.

Authors:  H Zhang; D H Fagan; X Zeng; K T Freeman; D Sachdev; D Yee
Journal:  Oncogene       Date:  2010-02-15       Impact factor: 9.867

Review 7.  Immature myeloid cells and cancer-associated immune suppression.

Authors:  Sergei Kusmartsev; Dmitry I Gabrilovich
Journal:  Cancer Immunol Immunother       Date:  2002-04-24       Impact factor: 6.968

8.  Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage.

Authors:  Matthew M Meredith; Kang Liu; Guillaume Darrasse-Jeze; Alice O Kamphorst; Heidi A Schreiber; Pierre Guermonprez; Juliana Idoyaga; Cheolho Cheong; Kai-Hui Yao; Rachel E Niec; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2012-05-21       Impact factor: 14.307

9.  Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody.

Authors:  Alain P Vicari; Claudia Chiodoni; Céline Vaure; Smina Aït-Yahia; Christophe Dercamp; Fabien Matsos; Olivier Reynard; Catherine Taverne; Philippe Merle; Mario P Colombo; Anne O'Garra; Giorgio Trinchieri; Christophe Caux
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307

10.  The perivascular niche regulates breast tumour dormancy.

Authors:  Cyrus M Ghajar; Héctor Peinado; Hidetoshi Mori; Irina R Matei; Kimberley J Evason; Hélène Brazier; Dena Almeida; Antonius Koller; Katherine A Hajjar; Didier Y R Stainier; Emily I Chen; David Lyden; Mina J Bissell
Journal:  Nat Cell Biol       Date:  2013-06-02       Impact factor: 28.824

View more
  20 in total

1.  Cancer Stem Cells in the Immune Microenvironment.

Authors:  Dong-Sup Lee; Keunhee Oh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer.

Authors:  Chelsea Hope; Philip B Emmerich; Athanasios Papadas; Adam Pagenkopf; Kristina A Matkowskyj; Dana R Van De Hey; Susan N Payne; Linda Clipson; Natalie S Callander; Peiman Hematti; Shigeki Miyamoto; Michael G Johnson; Dustin A Deming; Fotis Asimakopoulos
Journal:  J Immunol       Date:  2017-07-28       Impact factor: 5.422

3.  Reciprocal influence of B cells and tumor macro and microenvironments in the ApcMin/+ model of colorectal cancer.

Authors:  Francesca Mion; Stefania Vetrano; Silvia Tonon; Viviana Valeri; Andrea Piontini; Alessia Burocchi; Luciana Petti; Barbara Frossi; Alessandro Gulino; Claudio Tripodo; Mario P Colombo; Carlo E Pucillo
Journal:  Oncoimmunology       Date:  2017-06-19       Impact factor: 8.110

4.  The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion.

Authors:  Chunwan Lu; Amy V Paschall; Huidong Shi; Natasha Savage; Jennifer L Waller; Maria E Sabbatini; Nicholas H Oberlies; Cedric Pearce; Kebin Liu
Journal:  J Natl Cancer Inst       Date:  2017-01-28       Impact factor: 13.506

Review 5.  A new role for extracellular vesicles: how small vesicles can feed tumors' big appetite.

Authors:  Ikrame Lazar; Emily Clement; Camille Attane; Catherine Muller; Laurence Nieto
Journal:  J Lipid Res       Date:  2018-04-20       Impact factor: 5.922

Review 6.  The emerging link between cancer, metabolism, and circadian rhythms.

Authors:  Selma Masri; Paolo Sassone-Corsi
Journal:  Nat Med       Date:  2018-12-06       Impact factor: 53.440

7.  Trametinib Drives T-cell-Dependent Control of KRAS-Mutated Tumors by Inhibiting Pathological Myelopoiesis.

Authors:  Michael J Allegrezza; Melanie R Rutkowski; Tom L Stephen; Nikolaos Svoronos; Alfredo Perales-Puchalt; Jenny M Nguyen; Kyle K Payne; Sunil Singhal; Evgeniy B Eruslanov; Julia Tchou; Jose R Conejo-Garcia
Journal:  Cancer Res       Date:  2016-11-01       Impact factor: 12.701

Review 8.  Tumor-derived exosomes, microRNAs, and cancer immune suppression.

Authors:  Michael W Graner; Sathya Schnell; Michael R Olin
Journal:  Semin Immunopathol       Date:  2018-06-04       Impact factor: 9.623

Review 9.  Circadian Clocks and Cancer: Timekeeping Governs Cellular Metabolism.

Authors:  Amandine Verlande; Selma Masri
Journal:  Trends Endocrinol Metab       Date:  2019-05-30       Impact factor: 12.015

Review 10.  Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer.

Authors:  Chiara Camisaschi; Viviana Vallacchi; Elisabetta Vergani; Marcella Tazzari; Simona Ferro; Alessandra Tuccitto; Olga Kuchuk; Eriomina Shahaj; Roberta Sulsenti; Chiara Castelli; Monica Rodolfo; Licia Rivoltini; Veronica Huber
Journal:  Vaccines (Basel)       Date:  2016-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.